

These medicinal products require prescription either by primary care physicians or by specialists or form an integral part of hospital treatment.
Prescription Medicines, which represents the bulk of our Human Pharmaceuticals business, accounts for 77 percent of our total net sales and generated 9,7 billion euro in 2010.
Boehringer Ingelheim's product portfolio covers the following main indications: